Schroder Investment Management Group Decreases Stock Position in Colgate-Palmolive Company $CL

Schroder Investment Management Group lessened its stake in Colgate-Palmolive Company (NYSE:CL) by 0.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,307,715 shares of the company’s stock after selling 16,400 shares during the period. Schroder Investment Management Group owned about 0.66% of Colgate-Palmolive worth $424,299,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of CL. Tiemann Investment Advisors LLC boosted its stake in shares of Colgate-Palmolive by 2.1% during the second quarter. Tiemann Investment Advisors LLC now owns 6,083 shares of the company’s stock valued at $553,000 after purchasing an additional 125 shares during the period. S.A. Mason LLC increased its stake in shares of Colgate-Palmolive by 3.9% in the third quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock worth $280,000 after buying an additional 130 shares during the period. Security National Bank of Sioux City Iowa IA boosted its position in Colgate-Palmolive by 0.8% during the 3rd quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock valued at $1,298,000 after buying an additional 130 shares during the period. Stratos Wealth Advisors LLC grew its holdings in Colgate-Palmolive by 4.5% in the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after acquiring an additional 130 shares during the last quarter. Finally, Cordatus Wealth Management LLC increased its position in shares of Colgate-Palmolive by 0.6% in the second quarter. Cordatus Wealth Management LLC now owns 23,036 shares of the company’s stock valued at $2,094,000 after acquiring an additional 134 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the sale, the insider owned 17,645 shares in the company, valued at $1,663,041.25. This represents a 54.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CFO Stanley J. Sutula III sold 97,843 shares of the business’s stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total value of $9,223,659.61. Following the completion of the sale, the chief financial officer directly owned 55,310 shares in the company, valued at $5,214,073.70. This trade represents a 63.89% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 184,683 shares of company stock worth $17,486,693. 0.41% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research firms recently issued reports on CL. Rothschild & Co Redburn set a $93.00 target price on Colgate-Palmolive in a research note on Friday, February 13th. UBS Group lifted their price objective on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research report on Wednesday, January 14th. Evercore upped their target price on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, February 2nd. Citigroup boosted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the company a “buy” rating in a research report on Monday, February 2nd. Finally, Royal Bank Of Canada raised shares of Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 price target for the company in a research note on Tuesday, December 9th. Eleven equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $94.75.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $93.55 on Monday. The company’s fifty day moving average price is $88.98 and its 200-day moving average price is $83.03. The stock has a market cap of $75.41 billion, a PE ratio of 35.71, a price-to-earnings-growth ratio of 4.22 and a beta of 0.28. The company has a current ratio of 0.83, a quick ratio of 0.54 and a debt-to-equity ratio of 18.82. Colgate-Palmolive Company has a 12 month low of $74.54 and a 12 month high of $100.18.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.04. Colgate-Palmolive had a net margin of 10.45% and a return on equity of 353.72%. The company had revenue of $5.23 billion during the quarter, compared to analyst estimates of $5.13 billion. During the same period last year, the business earned $0.91 EPS. Colgate-Palmolive’s quarterly revenue was up 5.8% compared to the same quarter last year. On average, equities analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.2%. The ex-dividend date of this dividend was Wednesday, January 21st. Colgate-Palmolive’s payout ratio is currently 79.39%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.